Astellas Pharma (China)

Astellas Pharma (China)

Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Astellas Pharma (China), China, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

50%


Total
Publications

264


Total Open
Publications

132


Total
Citations

12K


Open Access
Percentage

50%


Total
Publications

264


Total Open
Publications

132


Total
Citations

12K

Wikipedia

Website

download

Breakdown

24% 17% 8% 51%

Publisher Open

24%

Both

17%

Other Platform Open

8%

Closed

51%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

38

Hybrid 21%

22

No Guarantees 43%

46

Other Platform Open

Domain 75%

51

Institution 16%

11

Other Internet 15%

10

Preprint 4%

3

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
51
DOI
Other Internet
10
Research Square
Preprint
2
Yonsei University Medical Library - YUHSpace
Institution
1
University of Zaragoza Repository - Zaguan
Institution
1
University of Michigan - Deep Blue
Institution
1
University of Melbourne - Minerva Access
Institution
1
University of Cantabria - UCrea
Institution
1
Universitat de Barcelona - Dipòsit Digital de la Universitat de Barcelona
Institution
1
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share